Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Basic helix-loop-helix ARNT-like protein 2 (BMAL2) is a transcription factor from the PAS (PER, ARNT, SIM) protein superfamily, and is structurally similar to BMAL1[2][4]. BMAL2 forms heterodimers with CLOCK or related proteins and is a core component of the molecular circadian clock, regulating transcription of genes involved in circadian rhythm, including period (PER) and cryptochrome (CRY) genes[2][5]. It binds to E-box enhancer elements in gene promoters and is crucial for the adaptive regulation of biological processes such as sleep-wake cycle, metabolic rhythms, and immune tolerance[2][3][5][6]. BMAL2 is also a regulator of immune responses in macrophages, where it upregulates PD-L1 expression, contributing to endotoxin tolerance—a process important in sepsis and immune suppression[1][5]. Pathologically, BMAL2 has been implicated in metabolic diseases, cancer (through immune checkpoint regulation), and disorders linked to circadian dysregulation[4][6]. There are no drugs currently known to directly target BMAL2, and its primary role is as a transcriptional regulator rather than a classical ‘receptor’ or enzyme.
Not applicable—no drugs are known to target BMAL2 directly; its activity is thought to regulate immune responses and circadian clock via gene expression and possibly those pathways are indirectly actionable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basic helix-loop-helix ARNT-like protein 2 (BMAL2).